阻塞性睡眠呼吸暂停的抗氧化疗法:系统性审查和元分析
Tarun Krishna Boppana1, Saurabh Mittal2, Karan Madan1
1Department of Pulmonary, Critical Care, and Sleep Medicine, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, India, 110029.
Sleep & breathing = Schlaf & Atmung
|May 13, 2024
概括
抗氧化剂治疗显著改善了阻塞性睡眠呼吸暂停 (OSA) 患者的内皮功能和睡眠质量. 这种方法可以减少氧化应激,但没有不良影响,这表明未来临床使用的潜力.
科学领域:
- 心血管医学 心血管医学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 与由氧化应激和交感性过度活动驱动的心血管问题有关.
- 针对氧化应激是一种潜在的治疗策略,用于OSA管理.
研究的目的:
- 系统地审查和元分析OSA患者抗氧化疗法的疗效和安全性.
主要方法:
- 在PubMed和Embase搜索了OSA患者抗氧化疗法的人类研究.
- 包括六项研究 (五项RCT,一项病例控制) 涉及160名OSA患者.
主要成果:
- 抗氧化剂显著改善了流媒体扩张 (FMD) 的2.16% (95% CI 1.65-2.67).
- 减少了甲和增加了谷氨水平,表明氧化应激减少.
- 改善了爱普沃思睡眠度量,氧气脱度指数和最小氧气和,没有不良影响.
结论:
- 抗氧化剂疗法增强内皮功能,减少氧化应激,并改善睡眠参数在OSA.
- 需要进一步的多中心研究和更长的随访,以证实抗氧化剂治疗OSA的有用性.
相关概念视频
Sleep Apnea
147
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
147
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
198
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
198
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
Sleepwalking and Sleep Talking
154
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
154


